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INTRODUCTION: 
Written records of man’s interest in the thyroid gland date from 
the second century A.D., when Galen described this organ and attributed 
to it the function of providing a lubricating fluid to the larynx and 
its cartilages to facilitate speech. This theory was accepted until 
as recently as the 17th century by such prominent scientists as Bartholin 
and Malpighi. In the 18th century and the early part of the 19th, the 
theory was proposed that the thyroid functioned "as a diverticulum in 
order to avert from the brain a part of the blood., which urged with too 
great force by various causes might disorder or destroy the functions 
of that important organ." Experimental research on the thyroid, however, 
was not perforemed to any appreciable extent until the latter half of the 
19th century; although from the fact that sheep’s thyroid was adminis¬ 
tered for the treatment of cretinism in China as early as the 6th century 
A.D., one can probably infer that physicians at that time were aware 
of some relationship between growth and the thyroid. From thyroidectomies 
on monkeys and carnivora, Horsley in 1885 supported the generalization 
proposed by Felix Simon two years previously that myxedema, cretinism, 
and operative cachexia strumipriva were all due to thyroid deficiency." 
And, in 1891 Murray restored myxedematous patients to normal health with 
£ o 
the administration of thyroid extract. 
Shortly after the turn of the 20th century, in 1911;, Kendall 
isolated from the thyroid gland an active principle in crystalline form 
which he named "thyroxin", <,L! In 1926 the constitution of this crystal¬ 
line substance was established by Harington to be that of an amino acid 
related to tyrosine, and this substance was subsequently synthesized,"-5 ^ 
. . • 
. 
. 
c 'i ' . " ■ 
$ ‘ "i S 
xS - 
.. 
, /Xi-o 2£ fif!.. rfD i;ii «2 n ie'i;- V dnoisdv iS $ & w" fo; %%!J 
.. _ , 
-i 
■: : rs ‘.<3/• ; . 
. 
;d fieri© 
- 2 - 
Since the isolation of thyroxine and diiodotyrosine from extracts of 
thyroid tissue and their synthesis, in the past forty odd years, much 
research has been carried out on the influence of the thyroid secretions 
on the processes of growth and developmentj on metabolic rate; carbo¬ 
hydrate, fat, and protein metabolism; and br\ the activity of various 
enzymic systems. Furthermore, numerous compounds other than thyroxine 
itself have been found to possess some of the activities of extracts 
of the thyroid gland. The literature on these various topics is so 
voluminous that no attempt to review them will be made in the present 
paper. Nevertheless, in spite of all these advances, one encounters in 
the 17th edition of the Textbook of Physiology edited by John F. Fulton 
in 1956 the following statement by Jane Russell: ’’fhe mechanism of 
action of the thyroid hormone is unknown,n^5 
Another momentous step in the understanding of the physiology and 
biochemistry of the thyroid was made when Gross and Pitt-Rivers identified 
the compound 1-3531 triiodothyronine in the plasma of patients after the 
administration of radioactive iodine.-3 The activities of this substance 
have subsequently been extensively investigated. It has been found to 
be three to four times as potent as 1-thyroxine in preventing the forma¬ 
tion of goitre in thiouracil-fed rats.4^' L-triiodothyronine given to 
a patient with classical myxedema was found to act much more rapidly 
than thyroxine in raising the Basal Metabolic Rate (BMR). but the total 
response to thyroxine was about threefold that of triiodothyronine. 
The same investigators studying the half-life of exogenously administered 
131 I J -labeled l-triiodothyronine and 1-thyroxine, discovered that of the 
former to be 2\ days and of the latter to be 7 to 12 days. '"' 
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In 1952, Harington and Pitt-Rivers synthesized the acetic analogue 
of 1-thyroxine.^ Subsequently tetraiodothyroacetic acid (TETRAC) has 
been identified in extracts of kidney and triiodothyroacetic acid (TRIAC) 
in extracts of liver from mice which had received an intraperitoneal 
injection of 1^^ eighteen to forty-eight hours prior to sacrifice.^ 
With intravenous injections of TRIAC into rats in doses as minute as l/l6 
ug and in intevals as frequent as one-fourth of a minute, Thibault has 
found that this compound, in contrast to thyroxine and triiodothyronine, 
exerts an immediate effect in increasing the oxygen consumption of the 
entire animal. Although the maximum effect was observed to be only about 
60% of that of thyroxine, but because this effect was detected immediately, 
Thibault postulated that thyroid hormones acted at the peripheral tissue 
level in the form of the acetic acid derivatives.‘ 4 Barker, however, 
was unable to find any evidence for the immediate action of TRIAC from 
his studies on oxygen consumption of tissue slices removed from animals 
following injections of this analogue.^ The question of the active 
form or forms of thyroid hormones at the level of peripheral tissues, 
therefore, still remains unsettled. 
In addition to thyroxine, triiodothyronine, and TRIAC about forty 
other thyroid analogues have been synthesized and studied in terms of 
their effectiveness in mammals in descreasing the uptake of radioactive 
iodine by thyroid gland, in preventing the development of goitre in 
animals fed with thiouracil, in enhancing the rate of basal metabolism, 
and in promoting the rate of metamorphosis of tadpoles. 353’ 1-triiodo- 
thyropropionic acid (TRIPROP) an interesting compound in this group, 
was found to be 300 times more potent than 1-thyroxine in accelerating 
. 
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metamorphosis of the tadpole, though only 3/b as efficacious in reducing 
the uptake of I1-’1 by thyroid gland of the rat, and \ as active in pre¬ 
venting the formation of goitre in rats fed with thiouracil. ^ 
However, at the time the present study was undertaken, very little work 
had been done concerning the actions of this substance in human beings* 
Although the symptoms and signs of typical cases of thyroid dysfunc¬ 
tion are well known, and diagnosis in such instances can be made without 
hesitation, there are many cases with atypical f eatures enabling one to 
make only an equivocal diagnosis. For many years the rate of basal 
metabolism has been used as an indication of thyroid activity, a rate of 
below - 20% being accepted as a criterion of hypothyroidism. However, 
it has been pointed out that the basal metabolic rate (EMR) has not 
proved to be an infallible guide in the diagnosis of thyroid dysfunction, 
as it may be low without the syndrome of sensitivity to cold, pnffiness 
of skin, coarse hair, and mental and physical retardation. On the other 
hand, Gildea, Man and Peters showed that with pre-treatment levels of serum 
cholesterol instead of BMR, one could predict with greater certainty the 
response of these patients to treatment with desiccated thyroid. They also 
found that serum cholesterol levels in hypothyroid patients were very sen¬ 
sitive to the administration of thyroid. Although in these patients, the 
amounts of total serum fatty acids tended to vary with the cholesterol 
levels, the relationship between the two was not strictly linear. Moreover, 
total fatty acid levels in hypothyroid people also seemed to be less res¬ 
ponsive to thyroid therapy."0 However, in contrast to the usefulness of 
serum cholesterol concentrations in predicting the response of hypothyroid 
states to treatment, they appeared to be of no assistance in predicting the res¬ 
ponse of questionable hyperthyroidism to thyroidectomy. In a study 
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of a series of forty-three patients exhibiting most or some of the 
classical symptoms of hyperthyroidism, Man, Gildea, and Peters observed 
that two of the patients with initially low lipid values showed little 
rise in serum cholesterol and other lipids although exhibited a definite 
reduction in BMP. after thyroidectomy. In 11 of 26 patients of this 
same series studied for more than six months following thyroidectomy, 
the serum lipids tended to level off to a plateau after a postoperative 
rise in spite of the fact that a concomitant elevation in BMR was not 
hi 
seen0"r~ 
Much evidence has been accumulated with regard to the relationship 
between thyroid function and lipid metabolism. Only a few examples will 
be cited. As early as 1917) Epstein and Lande noted that in diseases 
of the thyroid, serum cholesterol tended to vary inversely rdth the 
basal metabolism.^ Marx, Gustin, and Levi discovered that thyroxine 
stimulated and thyroidectomy depressed the incorporation of deuterium 
into cholesterol in the liver, intestine, kidneys, and spleen but not 
in the lungs of ratsj'1'4 Rats made hyperthyroid by feeding powdered 
thyroid were found to excrete at least twice as much cholesterol into 
the bile as the euthyroid controls, but rats treated with thiouracil 
excreted only about half the amount eliminated by control animals.h9 
Ard, as mentioned previously, hypothyroid patients after treatment with 
desiccated thyroid showed a reduction in levels of serum cholesterol 
concomitant with improvement in the clinical state.-1-0 Serum cholesterol 
levels, however, do not seem to be correlated closely with the body’s 
immediate caloric or metabolic requirements.- ^-5 On the other hand, 
the importance of serum ^ r £. e fatty acid (FFA) in the transport 
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of metabolic fuel has only very recently come to the foreground. 
In a group of 82 subjects from an unselected population. Dole 
observed that the fasting levels of FFA ranged from 0.31J? to 1.21 meq/l 
and that there was a r eduction of serum FFA of about 6$% one and half 
hour's after the administration of glucose and of about %0% two and half 
hours after the subcutaneous injection of insulin in a dose of 0.1 unit 
per kg of body weight." '" Similar observations were made independently 
by Gordon and Cherkes.-O Subsequently Bierman, Dole, and Roberts 
showed that although there was not much difference between the average 
fasting FFA levels in nondiabetic, obses individuals and diabetics 
without ketosis, diabetics in ketosis exhibited a definite elevation in 
serum FFA./ Gordon, Cherkes, and Gates from studying arterio-venous 
differences in human subjects have discovered that FFA concentrations 
in venous blood draining mainly subcutaneous tissues, such as that in 
the greater saphenous vein, are definitely higher than those found in 
arterial blood, which were again higher than those found in blood 
21 
samples obtained from the coronary sinus. More recently Carlson and 
Pernow have produced evidence to indicate an increased extraction of 
FFA from plasma by muscular tissues during moderate exercise in a fasting 
state,'' One can thus infer from these various experiments that serum 
concentrations of FFA vary inversely with the body’s need for or ability 
to utilize carbohydrate. Consequently, FFA levels are intimately related 
to the body’s metabolic requirements, and the FFA portion of serum 
lipids assumes an important role in the transport of fuel from the 
depots to the active tissues. Because of the significant position of 
FFA in the total metabolism, an inkling of the influence, if any, of 
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3^3! 1-triiodothyropropionic acid on lipid metabolism can perhaps be 
ascertained from a study of the effect that this particular thyroid 
analogue exerts on the nonesterified portion of the serum fatty acids. 
In investigations of whole-animal metabolism* one parameter that 
has often been used by physiologists is the respiratory quotient. The 
molecular structures of fats and carbohydrates are such that the com¬ 
bustion of a unit quantity of fats requires more molecules of oxygen 
than the combustion of an equal quantity of carbohydrates. With this 
fact as the basis for calculations* the percentage of fat or carbohydrate 
utilized in a certain period for the support of the organism’s metabolism 
can be estimated by measuring the total amount of carbon dioxide expired 
and oxygen used* and tables with this kind of information are available 
in most physiology textbooks. 
That euthyroid and hypothyroid people respond differently to 
exogenously administered thyroid substance has been demonstrated by 
Winkler* Riggs* and Man. In hypothyroid patients* desiccated thyroid 
in a dose sufficient to cause clinical improvement* but in all cases 
as small as 1 to 3 grains per day* was effective in elevating concen¬ 
trations of serum precipitable iodine (SPI) from below ug% to an 
average of 4.8 ug^a The increase in SPI per grain of desiccated thyroid 
was also remarkably constant* the mean being 2.0ug^ per grain with a 
standard deviation of + 0«5 ug$. On the other hand* in euthyroid sub¬ 
jects, frankly abnormal levels of SPI* i.e.* greater than 8ug$* were 
not consistently maintained until the dose of desiccated thyroid reached 
or exceeded 10 grains per day„^”* Furthermore* nonmyxedematous sub¬ 
jects can tolerate as much as 6 grains of desiccated thyroid for months 
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without any effect on pulse rate or BMR. Euthyroid subjects respond 
to intravenous thyroxine, but they require much larger doses than myxede¬ 
matous subjects for the same rise in BMRThis difference in response 
has been postulated to be on the basis of decreased inactivation of 
thyroid hormones in myxedematous individuals.-7, 72 
The present porject, then, is designed to study the influences, 
if any, of 353’ 1-triiodothyropropionic acid on plssna lipids and trans¬ 
port and utilization of fats in euthyroid human subjects with the hope 
that the results might contribute toward some understanding of the actions 
of substances possessing thyroid-like activities. 
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METHODS: 
The effects of 35>3‘ 1-triiodothyropropionic acid, (TRIPROP), on 
the levels of serum lipids in human beings were studied through both 
an acute and a more prolonged experiment. All experimental subjects 
were students at the Yale University Sch.ooi of Medicine with ages rang¬ 
ing between 23 and 26. At the time of the study, they were all enjoying 
good health. None of them had any previous history of hypothyroidism, 
hyperthyroidism, diabetes mellitus or essential hyperlipemia. Each of 
the two experiments will now be described separately* 
1. The acute experiment. Three subjects were studied: V.M., male 
J.W., femalej and P.L., male. After an overnight fast lasting for twelve 
to thirteen hours, blood samples were drawn early in the morning, 7:00 
or 8:00 a.m. or the arbitrary zero hour, of the control day for analyses 
of FFA, total fatty acids, lipid phosphorus/ and cholesterol, and gas 
samples were collected. Then at 1, 2, 5y? 8^-, 12, and 2k hours after 
the collection of the first sample, blood samples were obtained for the 
analysis of FFA. In addition, sufficient blood was collected for the 
study of lipid phosphorus, total fatty acids, and cholesterol at 8^ and 
2h hours after the first sample. Gas samples were obtained at 8f- 
and 2k hours after the first sample. Throughout these 2k hours after 
the overnight fast, subjects did not ingest any food but were allowed 
as much water as they liked. 
A rest period of one "week elapsed after the control day, and on 
the experimental day subjects were asked to carry out the same activities 
as on the control day. Every procedure on the experimental day was 
performed in a manner identical to that on the control day with the 
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following exceptions: (a) Subjects received TRIPROP" at a dose of 0.3 
mg/kg of body weight"-* immediately after the collection of the first 
blood and gas specimens at 0 hour, and (b) blood samples were obtained 
for the determination of butanol extractable iodine, (BEI), at 0, 1, 5^, 
8y, 12 and 2k hours from subject V.M. and at 0 and hours from subject 
P.L. 
2. The prolonged experiment. Four subjects were studied: W.R., 
male; M.W., female; E.L., female; and R.M., male. Blood and gas samples 
were collected at 8:00 a.m. In addition, subjects took their own pulse 
rate every morning upon arising; blood pressure was determined every 
day after the venepuncture; and daily weights were obtained. Subjects 
were allowed their regular diets and were asked to perform similar acti¬ 
vities every day. The control study took place on three consecutive 
days, and the experimental study was carried out through a period of 
six consecutive days following the control period. During the experimen¬ 
tal period, every procedure was the same as on the control day with the 
exception that each subject took TRIFR0P at a dosage of 0.3 mg/kg body 
weight every morning with his breakfast shortly after the venepuncture 
and gas collection for the respective day. However, the values of the 
day of the 
various determinations on the first^experimental period should actually 
be comparable to those of the control period, as subjects did not start 
* TRIPROP donated by Warner Chilcott. 
-K-K- This particular dosage was chosen mainly because some of Dr. 
M. J. Albrink’s patients were receiving as much, as 12-18 mg/d without 
any toxic effect. 
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taking TRIPROP until after the first venepuncture and gas collection. 
Determinations of plasma lipids and of respiratory quotients were performed 
daily,, BE I studies, however , were done only on the 1st, 3rd and 5 th 
days on subject M.W. and on the 1st, Uth and 6th days on subject E.L. 
All specimens used for the analyses of plasma lipids were venous 
blood samples drawn into heparinized syringes. From the syringe blood 
was rapidly transferred into round bottom pyrex tubes and centrifuged 
at room temperature at the rate of about 1^00 rpm for a period of 10 
minutes. For FFA determination, a proper aliquot of plasma was withdrawn 
into a calibrated Van Slyke pipette, transferred to a round bottom tube, 
and to it a measured amount of extraction mixture was added. The 
entire extraction procedure was carried out within thirty minutes after 
the venepuncture. For determinations of lipid phosphorus, cholesterol, 
and total fatty acids, plasma samples were stored in the refrigerator, 
and extraction procedures were carried out within one week after the 
venepuncture. Venous blood specimens for the study of BEI were drawn 
into heparinized iodine-free syringes prepared by Dr. E. B. Man’s lab¬ 
oratory. 
For the determination of respiratory quotient, gas samples were 
collected prior to the venepuncture in the following manner: each 
subject, after having had his nose artificially obstructed, breathed 
through a rubber mouth piece connected to a low pressure double-valve 
apparatus the outlet of which was in turn joined to a Douglas bag and 
the inlet of which communicated freely with room air. After the subject 
had been resting physically for at least 20 minutes, expired gas was 
collected for a period varying from 3\ to 5 minutes, the exact duration 
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being determined with a stop-watch. Gas samples were transferred 
into air-tight tonometers within 20 minutes after collection and the 
concentrations of carbon dioxide and oxygen were analyzed with a 
Scholander gas analyzer.^ 
All FFA determinations were performed according to the method of 
Dole-k- with the modification that instead of thymol blue, Nile blue 
prepared according to Gordon^ was used as the indicator. A palmitic 
acid standard extracted with the same procedures as the blood samples 
was run with each group of FFA determinations. Titrations for FFA 
levels of subjects of the acute experiment were performed with a 
Rehberg microburette and of the chronic experiment, with a Gilmont 
microburette. 
Extraction of pLasma lipids of subjects of the acute experiment 
were performed according to the method of Man and Gildea.39 Then 5 or 
8 ml aliquot of the alchol-ether filtrate was withdrawn for the deter¬ 
mination of lipid phosphorus by a modification of the method of Fiske 
6I4 
and Subbarow. For the determination of total fatty acids and total 
cholesterol, I4.O ml aliquot of the alcohol-ether filtrate was saponified 
with alcoholic potassium hydroxide, according to Man and G-ildea.39 
The remainder of the analysis was performed with the following modifi¬ 
cations. After evaporation of this alcohol-ether filtrate, the potassium 
salts of the serum fatty acids were acidified with concentrated hydro¬ 
chloric acid. The saponified free fatty acids were then suspended in 
about 12 ml of distilled water, and to this suspension was delivered 
exactly 20 ml of n-hexane measured with a volumetric pipette. This 
mixture in a stoppered flask was shaken vigorously and then transferred 
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into a 50 nil centrifuge tube. The centrifuge tube was fitted with a 
ground glass stopper and the mixture centrifuged for 20 minutes at 2000 
rpm. Then 1 or 2 ml aliquot of the upper hexane phase was withdrawn 
for titration of total fatty acids with 0.02N NaQH, and 3 ml aliquot 
of the same phase was obtained for determination of cholesterol by the 
method of Abell.^ 
Determinations of concentrations of total fatty acids, lipid phos¬ 
phorus and cholesterol of subjects of the chronic experiment were per- 
p 
formed with the extraction and titration of Albrink and the cholesterol 
method of Abell. 
All determinations on plasma lipid fractions were carried out in 
duplicates, and as many analyses of aliquots of gas from one single 
specimen as were necessary to give two values with a difference of not 
greater than 0.03$ were run with the Scholander apparatus. 
Lipid phosphorus determinations were carried out by Dr. Albrink's 
laboratory, and BEI determinations were performed by Dr. Man's laboratory. 
Analyses of all gas samples and of the remaining plasma lipid fractious 
were done by the author. 
The amount of total cholesterol in mg/100 ml was converted to the 
amount of cholesterol fatty acids in meq/l with the following formula: 
Choi fatty acid in meq/l = (chol in mg/lQQ ml) (0.72) (10) 
‘ —^ 
The amount of phospholipid fatty acids in meq/l was calculated from 
the amount of lipid phosphorus in mg/100 ml with the following formula: 
P lipid fatty acids meq/l = (10)(Lipid P mg/100 ml) [(u. j0)(2 )-fr0.2] 
31 
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These formulae are based on the assumptions that 72% of the serum choles¬ 
terol exists in the esterified form, that 80$ of the serum phosphopholipids 
contains two fatty acid molecules per mole of phosphorus (e.g. lecithin 
and cephalin), and that the remaining 20$ of the serum phospholipids 
contains only one fatty acid molecule per mole of phosphorus (e.g. sphingo¬ 
myelin). The amount of triglyceride fatty acids represents the difference 
between the total fatty acids and cholesterol fatty acids, phospholipid 
fatty acids, and FFA. Lipid phosphorus was converted into phospholipids 
by multiplying by a factor of 25; the cholesterol-phospholipid ratio 
was thus expressed as cholesterol in mg per 100 ml/(25) (lipid P in mg/ 
100 ml)? 
Calculations of respiratory quotients required certain assumptions, 
namely, that the composition of room air was essentially constant from 
day to day, that the percentage of oxygen in room air was 20.93$ and that 
of nitrogen 79»OU$, and that the concentration of carbon dioxide in room 
air was so minute that the volume of this gas expired per unit time 
could be considered to be equivalent to the volume of carbon dioxide 
produced by the body’s metabolism. The volume of gas collected in the 
Douglas bag was measured through a Precision Wet Test flowmeter under 
room temperature and pressure. The volume of gas expired per minute 
was then determined and corrected to standard temperature and pressure. 
The respiratory quotient was calculated with the following formulae: 
($ 02 in) ($ N2 in ) (corrected minute) 
lo 02 inhaled/min =(room air) (expired air) (vol. of exp, air) 
$ N2 in room air 
2. 02 expired/min = ($ 02 in exp. air) (corrected minute vol. of 
exp. air) 
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3. O2 utilized/min = O2 inhaled/min - 02 exhaled/min. 
i|. CO2 produced/min = (% CO2 in expired air) (corrected min* vol. 
exp. air) 
5. Respiratory quotient = ___C02 produced/min. 73 
O2 used/min 
It should be noted that the respiratory quotient thus obtained 
takes into consideration the combustion of carbohydrates, fats, and 
proteins. However, the amount of protein metabolized remains quite con¬ 
stant in an individual whose diet is about the same from day to day and 
in an individual undergoing a short term of starvation during which his 
liver glycogen and adipose tissues serve as the sources of metabolic 
fuel. 
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RESULTS: 
The acute experiment: 
The one study on the rate of absorption during fasting state and 
duration of effect of exogenous TRIPROP as measured by levels of serum 
BSI in subject V.M. revealed that the highest BEI level was obtained at 
£§■ hours after the ingestion of this compound (Table 8). However, since 
no blood sample was obtained prior to hours, one cannot be certain 
whether the peak level had not been reached any earlier. Two other 
similar studies, one while the subject abstained from food for 24 hours 
and the other while the subject was on a regular diet, showed that the 
peak BEI level in the former was reached two hours after administration 
of the drug, and in the latter, one hour after*' ' In all three cases 
BEI levels returned to approximately the original, i.e., pretreat¬ 
ment, values within four days after the administration of the 
drug. 
However, levels of BEI as high as 19 ug/100 ml of serum did not 
appear to have any definite or consistent effect on the concentrations 
of serum FFA, cholesterol, lipid phosphorus, triglycerides, and on the 
respiratory quotient (Tables 1-6, Figs 1, 3)* The levels of serum FFA 
in all subjects on both the control and experimental days reached a 
peak at the 12th hour* However, only one subject, V.M., showed a concen¬ 
tration higher on the experimental than on the control day, the level 
on the former being 1.23 meq/l, while that on the latter being 0*81 
meq/lo Subject P.L., on the other hand, actually showed the reverse 
pattern, namely, the peak level on the control day being 0.457 meq/l 
higher than that on the experimental day. In subject J.W., however, 
. -:.r*5;•£• ojiro£ an'.? 
. 
j . . . 
: . . ' , ... . • J'-f- .-'I . ' J r, 
I 
. -0 fic $ > 
, . <. 
. . *5 £ . > .. 
c v Jx 
t - 
. - ' 
dxic : «. <j 
. . . «; ^ • ,. . . 
nr. . *1,1 
. 
- 
, . 
. 
i 
„ . . 
- 17 - 
the curves of FFA levels on the control and experimental days can almost 
be superimposed on each other. 
With regard to the levels of plasma cholesterol, both P.L. and J.W 
exhibited an elevation as the end of the fasting,, control day drew near3 
P.L. showed an increase of 13.6$ and J.W., 8.6$. On the other hand, in 
both these subjects, concentrations of plasma cholesterol tended to 
fall as the experimental day progressed. The reduction, however, was 
small, being about 9*8$ in P.L. and only 3°7$ in J.W. In subject V.M. 
not much difference can be detected .in the fluctuations on both the 
control and experimental days. 
The levels of lipid phosphorus also showed a variable pattern. 
In subjects P.L. and J.W., thejlipid phosphorus, like the cholesterol, 
exhibited a rising trend on the control day and a failing trend on the 
experimental day. On the control day, in subject P.L., the level 
at the 2l|th hour was 17.6$ higher than that at the 0 hour: and in 
subject J.W., the increase was 1)4.1$. The same parameter was observed 
to fall by 9.7$ in P.L. and by 11.6$ in J.W. on the experimental day. 
The response seen in V.M. was quite different from that observed in 
the other two subjects. Instead of a tendency to reduction, the concen¬ 
tration actually rose by 16.2$ on the experimental day3 whereas on the 
control day, although there were some fluctuations within the first 
six hours, the level reached at the 2i|th hour was quite similar to t hat 
at the 0 hour. 
Tables #.1 and //I4 represent the levels of plasma total fatty acids 
and triglyceride fatty acids at various time intervals of the control 
and experimental days. Here each subject seemed to respond in his own 
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individual manner,, no definite pattern being established. 
Respiratory quotients are recorded on table #6. On both control 
and experimental days, all three subjects had a lower respiratory 
quotient at the 2l|.th hour than that at the 0 hour, the difference 
ranging from 0.09U to 0.193* on the control day. However, the degree 
of change on the experimental day was not significantly different 
from that seen on the control day, the difference between the 0 hour 
and the 2l;th hour ranging from O.Ol;? to 0.132. 
The chronic experiment: 
The results of this investigation revealed a few interesting 
points. In the first place, in subject M.W., the levels of BEI dropped 
in spite of continued administration of TRIFROP. The highest BEI 
level, 28.3 ug$, ’was reached after two daily doees of TRIPROP. After 
the lath daily dose, however, the BEI was only 19«9 ug$. The response 
in subject E.L., on the other hand, showed a continued rise with con¬ 
tinued treatment. (Table 20) 
The levels of plasma, cholesterol showed a consistent and consi¬ 
derable reduction with the administration of TRIFROP. This response was 
detectable as soon as one day after the first dose, and after 5 daily 
doses the cholesterol levels varied between 62 and 82$ of the initial 
values. Although the levels of cholesterol varied from day to day 
during the control period, the fluctuations, the greatest of which was 
10$, were insignificant compared to the response seen after the adminis¬ 
tration of TRIFROP (Fig. If) 
The FFA levels as can be seen from Fig. 2 did not show any 
. 
. 
t" • -t'Xrc fc■ 
$ •. cJ3 cra©xJot*n 
. . 
... o'tl ... .. 9*14 
:i©fp:9 '!■ r.io erP: 
. ..■ r.i ■ i*. 
. , _ 
. . • i - • ■ ’ 
. 
.■■ -J • i. ;fr v 
. 
— - 
.. j .'■■ i' 
x . 
. 
- 19 - 
consistent pattern with TRIPROP, As a matter of fact, they exhibited 
considerable variation within the control period. The total fatty 
acid levels in three of the four subjects showed a downward trend. 
However, this most likely was a reflection of the response observed 
in cholesterol. There is no dramatic or consistent change in cholesterol' 
phospholipid ratio (Table l£). 
No generalizations can be drawn from the responses of the respira¬ 
tory quotient. Here each subject appeared to react in a different 
manner. (Table llj.) 
The result of measurements of daily blood pressure was remarkable 
in that no consistent pattern could be detected (Table 19). The morning 
pulse rate, however, showed an upward trend; although after five daily 
doses of TRIPROP they were only from lli to 26 beats/min. more than the 
initial values (Table 18). All four subjects lost weight on the experi- 
mental regimen (Table 17). In two subjects, as much ’a reduction as 
A 
seven pounds in five days was seen. With the exception of the occurrence 
of mild headaches during the midst of the chronic experiment in two 
subjects, one of whom had the onset of menstrual period coincidem with 
the onset of the cephalalgia, and transient increase in perspiration 
in the other of these two subjects, TRIPROP in the dosage given here 
did not seem to cause any symptoms of nervousness, jitteriness, irrita¬ 
bility, increase in appetite, palpitation or diarrhea. 
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DISCUSSION AND CONCLUSION: 
In an attempt to locate the active site or sites of the thyroxine 
moleculej large scale investigations have been carried out on various 
metabolic activities of numerous compounds possessing the basic thyronine 
structure but with varying amino acid and fatty acid side chains as 
well as different number of iodides at various positions on the thyro¬ 
nine molecule.^* ^ A clearer concept of this particular approach 
can perhaps be grasped from examining the following representative 
formulae: 
35>3’ triiodothyronine 
HO 
I 
0 
I 
- CH - COOH 
I 
nh2 
1 353’ triiodothvroacetic acid 
HO 
I 
3531 triiodothyropropionic acid 
I | 
HO —<£T*>— o —eHV— ch2 ch2 COOH 
* I 
I I 
It has been found from these studies that within the vertebrates3 dif¬ 
ferent classes of animals respond differently to a certain chemical 
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substance; this phenomenon is, of course, by no means unusual in biology. 
For example, a study on the rate of metamorphosis of Rana pipiens tad¬ 
poles revealed that 35>3’ 1-triiodothyropropionic acid (TRIFROP) was 300 
times more potent than 1-thyroxine in accelerating this process 
but another investigation in the rat on the efficacy of various thyroid 
analogues in suppressing the formation of goitre in animals treated 
with thiouracil showed that TRIPROP possessed only 25% of the activity 
6< 
of 1-thyroxine. J 
A recent paper by Bauer, Me Gavack, and Swell reported that the 
administration of TRIPROP in a dose of 6 mg daily to euthyroid adults 
caused an average serum cholesterol reduction of 25$ after a period of 
two to four weeks,^ Turner and Steiner, in 19h5} showed that adminis¬ 
tration of desiccated thyroid in dosages varying from 30 to 2U0 rng/day 
to euthyroid subjects caused a sharp decrease in the levels of serum 
cholesterol.0’ However, from the studies so far available, one cannot 
arrive at any conclusion in regard to the relative activity of 1-thyro¬ 
xine and TRIPROP in this particular parameter. It is interesting to 
note, nevertheless, that the subjects of Bauer did not show much varia¬ 
tion of the BMR concomitant with the reduction in serum cholesterol, 
whereas the BMR's of Turner’s subjects were definitely elevated, with 
an average increase of 20$."3 0 The present work corroborated the 
results of Bauer in that significant reductions in serum cholesterol 
were evident after the administration of TRIPROP, The results in the 
present work were observed sooner than those in Bauer's; this fact can 
very likely be attributed to the larger dosage here used, TRIPROP, 
therefore, seems to exert the same influence on serum cholesterol as 
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thyroxine and triiodothyronine. Because the present experiment was 
carried out for only five to six days, one cannot predict froiti the 
available data the response of serum cholesterol to more prolonged treat¬ 
ment with TRIPROP at the constant dose of 0.3 mg/kg of body weight. Per¬ 
haps it would not be unreasonable to assume that a plateau will eventually 
be reached after a certain period and that further reduction in serum 
cholesterol will occur only upon the administration of a larger dose. 
Previous workers have concluded that adipose tissues appear to 
be more than normally active in hyperthyroid states. The low fasting 
respiratory quotients in patients with exophthalmic goitre^ and the 
J, 7 
predisposition to ketosis of hyperthyroid subjects^' suggest that mobi¬ 
lization and utilization of fats are accelerated. This hypothesis seems 
certainly to be substantiated by the work of Rich* Bierman, and Schwartz, 
who have demonstrated that the administration of 1-triiodothyronine in 
a dose of one or two mg led to a definite elevation in the level of 
serum FFA within 3 to 6 hours.-:’0 This is significant especially in view 
of the probable important role played by serum FFA in the transport of 
fat or metabolic fuel from sites of storage to sites of metabolic acti¬ 
vity. The present work, however,, does not show any consistent response 
of the levels of FFA to TRIPROP in as large a dose as 0,3 mg/kg. They 
seemed to vary up and down in spite of the TRIPROP. It is also difficult 
to interpret the data on the respiratory quotients (R. Q.), from the 
present study because not every subject responded in exactly the same 
manner. In the acute experiment, the R.Q. in all three subjects decreased 
as the day progressed. However, the percentage reduction in the R.Q. 
on the experimental day was not really significantly different from that 
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on the control day. Since the R.Q. reflects the relative proportions 
of carbohydrate and lipid metabolized by the body, and since the body 
must rely more and more upon the lipids as the metabolic fuel as the 
readily available supply of carbohydrate in the body becomes depleted 
with prolongation of starvation; it is understabdable that as the fasting 
day progressed, the R.Q.’s indeed became lower. In the chronic experi¬ 
ment, when the subjects were on their regular diets, one subject, M.W., 
showed a rather constant R.Q. throughout the four days that she was on 
TRIPROF. Another subject, E.L., showed a distinctly downward trend, 
the R.Q. on the last day of the experimental period being O.lli. lower 
than that on the first, pre-TRIPROP, day. Two other subjects, however, 
exhibited an irregular trend. From these data, one can only conclude 
that either TRIFROP exerts no effect on fat mobilization and utilization 
or other more potent factors are present. Because of the lability of 
the levels of FFA, its rate of turnover being extremely rapid with a 
half life of only two to three minutes,its sensitive response to 
changing concentrations of epinephrine and availability of serum glucose; 
because after 12 to 36 hours of fasting, the livers in different sub¬ 
jects may contain different amounts of glycogen; because of the uncon¬ 
trollability of the subjects1 psychological milieu, hence the secretion 
of epinephrine, during periods of experimentation; whatever effect 
TRIPROP might have on the levels of FFA can conceivably be obscured by 
the actions of these various factors. 
In the study by Rich, Bierman and Schwartz alluded to previously, 
it was shown that administration of 0.l£ or 0.2 mg of 1-triiodothyronine 
daily led to a definite, significant elevation in the BMR within the 
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first week of such treatment. This kind of effect, i.e., the effect 
of thyroxine and triiodothyronine on the BMR and the increased BMR 
observed in patients with Graves’ disease or toxic nodular goiter, have, 
of course, been observed by numerous other investigators. As in the 
case with the respiratory quotient, the present study does not permit 
any definite conclusion to be drawn regarding the effect of TRIPROP on 
this particular parameter of metabolic activity. The subject who 
exhibited the consistently downward trend in her R.Q.’s showed also a 
consistently upward trend in the BMR. However, since there was so much 
fluctuation in her BMR during the three days of the control period, it 
is very difficult to determine the significance of this upward trend 
during the experimental period. As a matter of fact, one cannot say 
unequivocally how much significance these nine figures on the BMR 
actually possess. The subject whose R.Q.’s were relatively constant 
throughout the experimental period revealed a consistently upward trend 
in the values of BMR, that on the last day of the experiment being about 
20% higher than that on the first day. The other two subjects again 
showed a random fluctuation, at least superficially. 
However, in view of the fluctuations seen in the values of both 
the R.Q. and BMR in all subjects even during the control period, one 
must cast some doubt on the accuracy of these determinations. Because 
of the method of gas collection, any degree of hypoventilation or 
hyperventilation will give rise to a misrepresentation of the actual 
amount of carbon dioxide produced and oxygen used by the body’s over¬ 
all metabolism. Since breathing through a rubber mouth piece with 
one’s nose artificially obstructed is not a natural respiratory avenue 
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and since the subject's equanimity might have been jeopardized by the 
previous venepuncture, it is easy for the subjects to hold their breath 
or to breathe unusually deeply even though they realize the importance 
of respiring naturally and are willing to cooperate. Furthermore, the 
resting period before the collection of gas was not rigidly controlled 
from day to day. The subjects rested from anywhere between 20 to 30 
minutes rather than a strict minimum of 30 minutes as has been suggested 
by other investigators.4 
Because of the inadequacy and imprecision of the determinations 
of BMR and R.Q., the varying response of the FFA levels in all seven 
subjects studied, and lack of information in the present-day scientific 
literature, no conclusion can be justifiably drawn concerning the 
influence of TRIPROP on the mobilization and utilization of lipids. 
Certainly more work of the kind performed in the present study, but 
perhaps with varying dosages of TRIFROP, concomitant investigation of 
the levels of serum glucose, and more uniform conditions for the gaseous 
studies, will be needed before one can arrive at meaningful impressions 
and conclusions. Even then, only the pharmacologic rather than the 
physiologic activities of TRIPROP on lipid metabolism can be elucidated. 
That TRIPROP exerted some metabolic effects, however, was evident 
from the fact that all subjects in the chronic experiment showed weight 
loss ranging from about 2.5 to 7 lbs in the four to five days that they 
were receiving TRIPROP. Moreover, by the end of the experiment, all 
subjects had a pulse rate higher than their initial one, the increment 
ranging from lU to 22 beats per minute. These effects are similar to 
those seen in people in various states of hyperthyroidism, be they 
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pathologically produced as in Graves’ disease and toxic nodular goitre, 
or artifically induced with the treatment of thyroxine or triiodothyro¬ 
nine. It must be mentioned, however, that TRIPROP did not lead to any 
elevation of systolic pressure. Moreover, with the exception of occur¬ 
rence of mild headaches in two subjects after the 2nd and 3rd doses 
of TRIPROP and slight hyperhidrosis in one of these two subjects, the 
common symptoms of hyperthyroidism were absent. It can at least be 
said, then, that TRIPROP in some ways duplicate some of the effects 
of the ’’natural” thyroid hormones. But whether all these different 
compounds act at the same loci is still a very unsettled question. 
Another interesting aspect of the activity of thyroid hormones 
and analogues centers upon the questionable likelihood of a dissocia¬ 
tion of action. For the past four decades, it has been known that 
hyperthyroid human subjects exhibit an exaggerated or hypersensitive 
response to exogenously administered epinephrine, manifesting increase 
in heart rate, blood pressure, tremor, and palpitations. With carefully 
regulated intravenous infusions of epinephrine into euthyroid and hyper- 
thyroid. subjects as well as patients with normal thyroid function but 
other hypermetabolic conditions such as Hodgkin’s disease, lymphosarcoma 
and anxiety neurosis; Murray and Kelly demonstrated that euthyroid 
individuals could tolerate infusion rates of epinephrine up to 0.2 
ug/kg/minute before experiencing symptoms of epinephrine toxicity, 
whereas hyperthyroid patients could tolerate only fractions of this dose 
Although euthyroid subjects responded to the administration of epine¬ 
phrine with an elevation of pulse rate and blood pressure and an 
increase in oxygen consumption, the hyperthyroid subjects did so 
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much more dramatically. The response of serum cholesterol* however* 
was variable and unpredictabled0 Other investigators have demonstrated 
that the oral administration of reserpine to patients suffering from 
thyrotoxicosis reduces their basal metabolic rate* heart rate* and 
blood pressure although exerts no measurable influence on either the 
level of protein-bound iodine or the uptake of radioactive iodine by 
q 
the thyroid gland. However* the increase in peristaltic activity of 
the gastrointestinal tract* a prominent feature of hyperthyroid 
states* is actually reversed by epinephrine,5® Perhaps some effects 
of thyroid function are indeed mediated through epinephrine* which for 
some yet unknown reason appears to be more active in subjects with 
hyperthyroid states. 
With regard to the cholesterol-lowering effect of thyroid hormones* 
Lerman and Pitt- Rivers reported two cases of myxedema that showed a 
prompt clinical response and a rapid fall in serum cholesterol but 
no change in the BMR after treatment with TRIAC.Subsequently similar 
work was repeated by Trotter, who administered to two myxedematous 
patients TRIAC* triiod.oth3rron.ine* and thyroxine in dosages of 2-6 mg q.d.* 
Q.OU - 0.08 mg q.d.* and 0.1 - 0.2 mg q.d.* respectively but found the 
responses in the fork of reduction of serum cholesterol and elevation 
of BMR to all three substances to be very much alike. Trotter then 
studied the reaction of four euthyroid subjects to the administration 
of gradually increasing doses of TRIAC* up to 1* mg q.d. for a period 
of about seven months. The result in one of the four cases was unaccep¬ 
table as the serum cholesterol level was for some unknown reason already 
falling at the time TRIAC was given* but in the other three subjects 
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there was a definite fall in the serum cholesterol although the Bin 
rose only very slightly.^7 In a more recent double-blind study using 
triiodothyronine, thyroxine, and TRIA.C in relative doses of 1:5:50 and 
lactose as placebo in subjects with nontoxic goitre, Doniach, Hudson, 
Trotter, and Waddams demonstrated that all three thyroidal substances 
in such dosage were equally effective in reducing serum cholesterol; 
but symptoms of clinical hyperthyrodism were observed in none of the 
nine subjects receiving triiodothyronine, in six of the nine subjects 
receiving thyroxine, and in three of the thirteen subjects receiving 
TRIAC.^3 The average maximal change in BMR was +$,k5/o in those subjects 
on triiodothyronine, +33*55$ in those on thyroxine, and +7.85$ in 
those on TRIAC.^ Interpretation of the results of these various 
investigations can only be difficult and uncertain, for it is con¬ 
ceivable that different results would be demonstrated by using differ¬ 
ent dosages of the drugs. However, one can probably conclude that 
both TRIAC and triiodothyronine, in a dosage comparable to thyroxine 
in terms of the effectiveness in reducing serum cholesterol, seem to 
exhibit less effectivenessthan the latter in causing an elevation of 
BMR and the appearance of subjective symptoms of nervousness, irritabi¬ 
lity, perspiration, tiredness and diarrhea. 
However, it has been demonstrated by Rich, Bierman, and Schwartz 
that the intravenous administration of triiodothyronine to euthyroid 
resulted 
subjectsAin a definite rise in oxygen consumption after three to six 
hours but no change in the level of serum cholesterol within the same 
period, although the latter was reduced within the first week of con¬ 
tinuous oral administration of this compound. There was also a definite 
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elevation in the plasma FFA concentration with the rise in oxygen con¬ 
sumption. 57 On the other hand, studying the effect of TRIFROP on 
serum cholesterol and BMR Bauer found that oral administration of 
6 mg q.d. for two to four weeks led to a significant reduction in the 
serum cholesterol but essentially no change in oxygen consumption.5 
The results of the present study are in agreement with those of Bauer's 
investigation. 
Recently the relationship between thyroid function and plasma 
cholesterol has been investigated from a new and interesting viewpoint, 
namely, through the interaction of androsterone, which is one of the 
metabolic products of testosterone. The urinary excretion of androsterone 
and the conversion of exogenously administered testosterone to andros¬ 
terone have found to be decreased in hypothyroid states. The produc¬ 
tion of androsterone relative to etiocholanolone is returned, to almost 
normal degree by therapy with triiodothyronine. Administration of 
androsterone has been observed to lead to a reduction in levels of 
plasma cholesterol not only in myxedematous patients, but also in euthy¬ 
roid patients with hypercholesteremia due to other causes and in subjects 
with both normal thyroid and cholesterol states. " One subject studied 
exhibited an increase in basal oxygen consumption of about ±6% in 
addition to the reduction in serum cholesterol after receiving andros¬ 
terone. It is thus interesting to speculate on the "thyromimetic" 
activity of androsterone on cholesterol. Is the cholesterol-lowering 
action of thyroid hormones mediated through an increase in the produc¬ 
tion of androsterone? How does an increase in thyroid function lead to 
an increased production of androsterone? Through what mechanisms does 
■ - 
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androsterone act to effect the observed changes in serum cholesterol? 
Does androsterone have any other thyroid-like activities such as 
acceleration of pulse rate, increase in body temperature, enhancement 
of gastrointestinal motility, and elevation of systolic pressure? Is 
this another case for the ”dissociation of actions” of the thyroid 
hormones? At present, there are no satisfactory answers to these 
questions. Further research in these various directions would undoubt¬ 
edly be fruitful. 
From the maze of data presently available, no final word can yet 
be said in regard to the hypothesis of dissociation of actions of thy¬ 
roid hormones. The present study has not contributed substantial infor¬ 
mation to the elucidation of this problem but has shown that the adminis¬ 
tration of large doses of 353’ 1-triiodothyropropionic acid can lower 
plasma cholesterol without causing any of the toxic symptoms of hyper¬ 
thyroidism. If indeed there be a real dissociation of the various 
activities of the thyroid hormones, most likely this dissociation would 
exist between the two types of effects mentioned previously, namely, 
the actions leading to a lowering of serum cholesterol and those giving 
rise to symptoms possibly associated with a heightened epinephrine effect, 
such as jetteriness, nervousness, palpitation, tremor, and elevation of 
blood pressure. 
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SUMMARY: 
1, The effect of 353’ 1-triiodothyropropionic acid on plasma lipids 
was studied by the administration of this substance in a dosage of 0.3 
mg/kg of body weight to three subjects in an acute experiment and to four 
subjects in a chronic experiment; the analyses of plasma BEI, FFA, total 
fatty acids, triglyceride fatty acids, phospholipid fatty acid: and 
determinations of respiratory quotient and basal metabolic rate. The 
acute experiment lasted, for 21| hours, during which the subjects fasted. 
The chronic experiment lasted for a period of five to size days, during 
which the subjects were on their regular diets. All blood and gas samples 
were collected early in the morning after an over-night fast. 
2. Daily weights and measurements of pulse rate and blood pressure 
were obtained on subjects of the chronic experiment. 
3» Wo consistent effect of 353’ 1-triiodothyropropionic acid on 
plasma FFA, triglyceride fatty acids, phospholipid fatty acids, respira¬ 
tory quotient, and basal metabolic rate were observed. 
h* While on 353’ 1-triiodothyropropionic acid, subjects of the 
chronic experiment showed a reduction of plasma cholesterol level of 
from 18 to 38$, a weight loss of from 2.5 to 7lbs in five days, an 
increase in pulse rate of from lU to 26 beats/minute, but no consistent 
or significant change in blood pressure. 
5* Evidence was presented and discussed in relation to the 
possibility of a dissociation of the actions of thyroid hormones and 
analogues. 
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Table 1 - Acute Experiment - Plasma Total Fatty Acids in meq/L 
V.M. J.W. P.L. 
Control Exp. Control Exp. Control Exp. 
0 hr. 10.22 9.02 9.U2 9*U6 12.92 11,58 
1 hr-. 9.86 9.67 __ 
2 hr. 10.U _ , J . _ r _ _, . 
5i hr. 9.6 
8^- hr. 9.93 mml 9.79 10*25 13.29 11.28 
12 hr. 9.86 ^. . _- - . _ . 
2k hr. 9.52 —» 12*83 10 .-7-5 13.08 9.16 
Table 2 - Acute Experiment —— Plasma FFA in meq/L 
V.M. J.W. P.L. 
Control Exp, Control Exp. Control, Exp. 
0 hr. 
.757 .392 o3k .3h ,321 .36 
1 hr. .618 0I4-O6 »h9 .31 • 35 
2 hr. .636 ,U55 ,58 .66 _ . 
Si hr. .6ia .569 ,82 •72 •5Ul 
8i Hr. ,631 .916 .70 .92 * >OP .68 
12 hr. .81-1 1,23 2.29 2.18 1.3 • 8U 
2li hr. ,686 
.791 1.5 1,28 1.11 .77 
uoiraA •;'fo’eri o ' s.. - 
- 
, : : 
. J ' 
* I 
1. 
- ■; . ad - elds? 
- 33 - 
Table 3 -— Acute Experiment - Plasma Cholesterol in mg/100 ml 
V.M. J.W. P.L, 
Control Exp. Control Exp* Control Exp* 
0 hr. 176 158 175 161 199 18U 
1 hr* 179 155 .M> , 
2 hr* 
c-—
 
0
0
 
1
—i
 16b —— 
hr« 185 155 
8^- hr* 180 151 id
 
"
 
! 
162 210 171 
12 hr* 178 I5l 
2b hr* 180 161 190 155 226 166 
Table b —- Acute Experiment — Plasma. Triglyceride Fatty Acids in meq/L 
V.M. J.W. P.L. 
Control Exp. Control Exp. Control Exp. 
0 hr* 2,023 1*738 0.66 1.03 3.61 2.98 
1 hr* 1.892 2,37U _T r ..„ . .. _ 1 T 
2 hr, l.b9b . - _ _ gl Ml , _ 
5| hr. 1.UU9 — mrI „ ,, 
8^- hr. 1,6149 -mL_ 0.86 1.38 3*79 2.97 
12 hr. 1.52U _, _ _L Mlll, , _ ari 
2I4 hr. 1.18U — 1*53 2.08 — 1.17 

- 3h - 
Table 5 Acute Experiment — Plasma Lipid Phosphorus in mg/100 m3. 
7.Si I. J.W. p T, 1 a J-J a 
Control Exp. Control Exp. Control Exp. 
0 hr 0 7.17 6,8 8.9 8.78 
C
O
 
C
O
 
8.0 
1 hr. 6.92 6.9 
2 hr. 8.25 __ t« — ,_ __,t_ __L 
hr. 7.0 _. „ ■ ■ ■■ r ■ . L, T„, 
»
 
£
 
h|oj
 
C
O
 7 Jj. 8.5 8.5 7.6 7 .UP 
12 hr. 7.25 -,u. .. t__ M 
2li hr. 7.U -- 10.8 7.8 —, 6.85 
Table 6 —- Acute Experiment Respiratory Quotient 
V.l I. J.W. P.L. 
Control Exp. Control Exp. Control Exp. 
0 hr. ,827 ,828 .825 .825 
.8U5 .889 
1 hr. ... 
2 hr. _ . _ 
Site. .709 .709 .733 .727 .810 .78 9 
8|- hr. .8ii •7U ,?08 .77 .837 .79 
12 hr,    
2k hr. 
.733 .696 .632 .758 • 7bl .77 
- . ' L • o' C ■ • - 
[-■"io' ' 
9 
» ... 
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Table 7 —- Acute Experiment —- Cholesterol-Phospholipid Ratio 
V.M. J.W. P.L. 
Control Exp. Control Exp. Control Exp. 
0 hr. .982 .93 .786 °73b .90U .92 
1 hr* 1.035 .898 
2 hr. ,907 _r .,T1cjr, _ 
51 hr. 1,0^6 . , mi n _ m - ,r 
8-|- hr. ,973 o833 ,762 1.105 ,92U 
12 hr. ,982 T““* 
2k hTo .973 — -70U .80 .97 
Table 8 —- Acute Experiment -— Butanol Extractable Iodine in ug/100 ml 
V.M. J.W. P.L, 
0 hr. 3.8 - ko2 
1 hr, after TRIPROP 12.0 , M 
2 hr 0 after TRIPROP 
5| hr. after TRIPROP 19.1 ,nM , T 16.7 
8i hr, after TRIPROP 12.6 Ml „„ _ 
12 hr. after TRIPROP 11.3 ___ 
2k hr. after TRIPROP 11.3 — — 
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